NASDAQ: ALLO · Biotechnology
Over the past week, Allogene Therapeutics (ALLO) saw 8 mentions across Reddit, X and news, and the read is an Adanos Hold. That is too little tracked discussion to read a direction from, so the signal stays neutral. Wall Street is more constructive, with 11 of 13 analysts rating ALLO a buy.
Tracked discussion on ALLO is too thin this week to read a direction from, which is why it reads as a Hold.
Wall Street’s 85% buy share sits next to a crowd that ranges from News at 0% to Reddit at 100%. No other tracker puts the two side by side.
Across 13 analysts the consensus is a Strong Buy: 11 buy calls against 0 sell, with an average 12-month price target of $9.00.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week ALLO carries too few tracked mentions to weigh any of them, so the read is Hold rather than a clear buy or sell.
Analysts sit 35 points above the crowd average of 50%, the professionals are more constructive than retail. The split is inside the crowd: Reddit reads 100% bullish while News sits at 0%, a 100-point spread that single-source trackers miss.
Over the 30-day window, Allogene Therapeutics (ALLO) buzz held moderate around 41.2 while the price drifted down 21.6% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 8.5M shares. Updated Jul 27, 2026. Over the last 7 trading days, ALLO lost 2.8%. Buzz activity in the recent week averaged 36.4 and was relatively stable, swinging between 24.9 and 41.2. Recent volume is running below the 30-day average, pointing to quieter participation. Daily crowd sentiment leaned bullish on 5 of the 10 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Buzz, bullish share, the loudest item and the positive / neutral / negative split for every tracked source over the last 7 days.
No Polymarket data for this stock this week.
Query sentiment for ALLO and 1000+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ALLO sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Jul 27, 2026.
Adanos will not call Allogene Therapeutics (ALLO) either way right now. The last 7 days carry 8 tracked mentions across 3 sources, under the 10-mention floor, so the signal sits at a neutral hold with 40/100 conviction. This is a sentiment-based reading, not financial advice.
Reddit discussion around Allogene Therapeutics (ALLO) is fairly quiet with 1 mentions across 1 tracked subreddits. The tone is 100% bullish with stable 3-day activity momentum, suggesting steady attention.
There is not enough tracked discussion on Allogene Therapeutics (ALLO) to call it either way. The last 7 days carry 8 tracked mentions across 3 sources, under the 10-mention floor Adanos needs before it reads a direction. On the professional side, 11 of 13 analysts rate ALLO a buy.
Of the 13 analysts covering Allogene Therapeutics (ALLO), 11 rate it a buy, 2 a hold and 0 a sell, for a strong buy consensus. The average price target is $9.00. That puts the street ahead of the crowd, which averages 50% bullish.
Allogene Therapeutics (ALLO) does not carry enough tracked discussion this week to have a readable sentiment. 8 mentions across 3 sources is under the 10-mention floor, so the signal stays neutral at 40/100 conviction.
Not for a reason found in the sentiment itself. Allogene Therapeutics (ALLO) drew 8 tracked mentions in the last 7 days, too small a sample to read a direction from, so Adanos holds the signal neutral instead of calling a buy or sell off it.
X is the dominant discussion channel with 6 mentions (75% of total volume). Reddit contributes 1 mention and News contributes 1 mention. There is too little of it to read a sentiment direction from, while news is the only source with rising 3-day activity.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ALLO's hold signal at 40/100 conviction reflects a sample too thin to read a direction from. It is a research shortcut, not financial advice.
The ALLO sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
These stocks share a comparable sentiment profile to Allogene Therapeutics with similar bullish ratios, signal direction and discussion volume. All 6 peers carry hold signals, pointing to broad mixed pressure rather than an ALLO-specific issue.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key